Gastroesophageal Junction Clinical Trials

ReadTheTrial indexes 1 studies for Gastroesophageal Junction. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Gastroesophageal Junction.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Gastroesophageal Junction

A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma): Substudy 06C

NCT06469944 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Gastroesophageal Junction?

There are 1 clinical trials listed for Gastroesophageal Junction. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Gastroesophageal Junction trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Gastroesophageal Junction trials in?

Current Gastroesophageal Junction trials are distributed across: Phase 2 (1).

Find More Trials